GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organigram Global Inc (TSX:OGI) » Definitions » Revenue

Organigram Global (TSX:OGI) Revenue : C$166.1 Mil (TTM As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Organigram Global Revenue?

Organigram Global's revenue for the three months ended in Dec. 2024 was C$42.7 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was C$166.1 Mil. Organigram Global's Revenue per Share for the three months ended in Dec. 2024 was C$0.38. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was C$1.81.

Warning Sign:

Organigram Global Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Organigram Global was -5.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -4.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 20.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 12 years, Organigram Global's highest 3-Year average Revenue per Share Growth Rate was 106.30% per year. The lowest was -4.90% per year. And the median was 59.25% per year.


Organigram Global Revenue Historical Data

The historical data trend for Organigram Global's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organigram Global Revenue Chart

Organigram Global Annual Data
Trend Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.41 86.80 79.16 145.81 159.84

Organigram Global Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.46 37.63 41.06 44.70 42.73

Competitive Comparison of Organigram Global's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organigram Global's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organigram Global's Revenue distribution charts can be found below:

* The bar in red indicates where Organigram Global's Revenue falls into.


;
;

Organigram Global Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$166.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organigram Global  (TSX:OGI) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Organigram Global Revenue Related Terms

Thank you for viewing the detailed overview of Organigram Global's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Organigram Global Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds brands, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
Executives
Paolo De Luca Senior Officer
Dexter John Director
Katrina May Mcfadden Senior Officer
Donald Geoffrey Machum Director
Stephen A. Smith Director
Derrick West Senior Officer
Sherry Porter Director
Michel Bourque Director
Kenneth Arnold Mitton Director
Denis Joseph Robert Arsenault 10% Security Holder, Director, Senior Officer